(UPDATED) If there’s an area of cardiology in need of reconciliation, revascularization of left main coronary artery disease would be a worthy candidate given the acrimony of the past few years. Now, ...
MADRID — New data from two randomized trials suggest that dual antiplatelet therapy (DAPT) should be significantly shortened or not used at all after coronary artery bypass surgery (CABG). Researchers ...
Addition of the PCSK9 inhibitor evolocumab to statin therapy after cardiac bypass surgery did not improve 24-month graft patency in the NEWTON-CABG CardioLink-5 trial. Subodh Verma, MD, cardiac ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback